AIScriptReader 记录了 3,276 月访问量，月度环比增长为 +8%，定价为付费。Command Code 记录了 2,358,177 月访问量，增长率为 -12.1%，定价为免费增值，定价请咨询。
会学习你编码品味的 AI 编程智能体
| 维度 / 指标 |  | |
|---|---|---|
| 官方域名 | aiscriptreader.com | commandcode.ai |
| 定价模式 | 付费 | 免费增值，定价请咨询 |
| 月访问量 | 3276 (3,276) | 235.82万 (2,358,177) |
| 月度环比流量变化 | +242 (+8%) | -32.57万 (-12.1%) |
| 主要市场与份额 | 🇺🇸 美国 (97.4%) | 🇨🇳 中国 (47%) |
| 直接访问 / 月 | 1294 | 174.96万 |
| 用户评分 | 3.8 | 4.3 |
| 支持的平台 | 网站 | 网站 |
即时 AI 剧本分析与开发意见
在一份文档中结构化呈现一句话故事、剧情梗概、人物分析、主题、结构与市场潜力。
细致到具体场景与版本的优劣势标注和修改建议。
就人物、情节和主题继续提问，获得针对你剧本的个性化建议。
上传多部剧本，将所有审读记录、报告与意见集中在一处管理。
会学习你编码品味的 AI 编程智能体
持续强化学习层把每一次采纳、拒绝和手动编辑变成信号，再把反复出现的模式转化为可复用的项目级技能。
自动修复格式错误的工具调用，让较弱的开放权重模型也能可靠完成智能体循环，接近前沿模型的水平。
交互式 CLI 用于结对，无头标志用于脚本化，后台沙箱智能体则用于更长时间的自主任务。
自定义 /agents 与持久化 /memory 跨会话携带项目上下文，让你不必反复解释代码库与规范。
专项更强Offers industry-leading reasoning and artifact generation, but lacks direct terminal-first integration and local preference memory.
免费 / 开源Orchestrates multiple CLI coding agents in parallel git worktrees, but is less focused on single-user preference learning.
免费 / 开源Type.ai is an AI writing assistant and full document editor for long-form creative writing, built for authors, novelists and screenwriters who need to draft and revise book-length work in one place.
免费 / 开源Type.ai is an AI writing assistant and full document editor for long-form creative writing, built for authors, novelists and screenwriters who need to draft and revise book-length work in one place.
免费 / 开源Paper Digest is an AI research platform that summarizes literature, generates literature reviews with citations, and delivers daily digests of new papers across arXiv, PubMed, bioRxiv and major conferences. Launched in 2018 and used by millions of researchers, it combines a citation-backed review engine that avoids inventing results with tools for reading PDFs, writing, question answering, claim verification and topic tracking.
免费 / 开源Paper Digest is an AI research platform that summarizes literature, generates literature reviews with citations, and delivers daily digests of new papers across arXiv, PubMed, bioRxiv and major conferences. Launched in 2018 and used by millions of researchers, it combines a citation-backed review engine that avoids inventing results with tools for reading PDFs, writing, question answering, claim verification and topic tracking.
